---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-009401"
form_type: "8-K"
ticker: "CELZ"
cik: "0001187953"
company_name: "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."
filed_at: "2022-12-19T23:59:59+00:00"
generated_at: "2026-06-21T02:23:35.233152+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Creative Medical Technology shareholders elect all directors, approve executive compensation and auditor ratification

## Summary
- Seven directors elected with votes ranging from 2,675,852 to 2,694,252 in favor; no withhold above 361,796.
- Executive compensation approved with 2,422,079 for, 588,661 against, 26,908 abstain, 4,818,286 broker non-votes.
- Advisory vote on executive compensation set to every one year, approved with 2,854,354 for one year.
- Ratification of Haynie & Company as auditor approved with 7,690,484 for, 144,871 against, 20,579 abstain.

## SEC filing metadata
- accession: 0001477932-22-009401
- form_type: 8-K
- ticker: CELZ
- cik: 0001187953
- company_name: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- filed_at: 2022-12-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/celz_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-009401
- JSON: https://secwatch.observer/filing/0001477932-22-009401.json
- Plain text: https://secwatch.observer/filing/0001477932-22-009401.txt

## Key facts
- Shareholder Votes
  CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Approval of the compensation of the Company's named executive officers at the 2022-12-19 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-19
  source text: Proposal II - The compensation of the Company’s named executive officers was approved as follows: For Against Abstain Broker Non-Votes 2,422,079 588,661 26,908 4,818,286
  evidence_url: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm
- Shareholder Votes
  CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Election of the five director nominees named in the Proxy Statement at the 2022-12-19 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-19
  source text: The five director nominees were all elected to the Board as follows: Director For Withhold Timothy Warbington 2,694,252 343,196 Donald Dickerson 2,693,855 343,793 Michael H. Finger 2,675,852 361,796 Susan Snow 2,690,084 347,564 Bruce S. Urdang, Esq. 2,677,918 359,730
  evidence_url: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm
- Shareholder Votes
  CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Ratification of appointment of Haynie & Company as independent registered public accountants at the 2022-12-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-19
  source text: Proposal IV - The ratification of the appointment of Haynie & Company was approved as follows: For Against Abstain Broker Non-Votes 7,690,484 144,871 20,579 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm
- Shareholder Votes
  CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Advisory vote on frequency of executive compensation votes at the 2022-12-19 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2022-12-19
  source text: Proposal III – Holding an advisory vote on executive compensation on an annual basis was approved as follows: One Year Two Years Three Years Abstain Broker Non-Votes 2,854,354 33,493 116,755 33,046 4,818,286
  evidence_url: https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.